Barber & Odean's Nobel-adjacent 2000 study, validated by SEBI's 2024 evidence that ~93% of Indian retail F&O traders lose money, explains the meta-bias that makes every other cognitive error worse — and the 8-question pre-trade checklist that disarms it.
Titan Biotech ended FY25 with an 11-member board, four independent directors, an independent chair, and 14 board meetings - a governance structure that merits serious attention from long-term investors.
Deferred tax can quietly change how reported profit should be read. The line is less about jargon and more about timing, profit quality, and whether management disclosure deserves trust.
A rights issue can preserve minority ownership or quietly dilute it. The difference lies in why the company needs money, how management behaves, and whether investors understand their rights entitlement before it lapses.